• 目的评价肝安高脂血脂肪肝炎疗效

    Objective To evaluate the therapeutic effect of Ganan decoction in hyperlipidemic fatty hepatitis.

    youdao

  • 联合治疗未来非酒精性脂肪肝炎临床试验范例吗?

    Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?

    youdao

  • 此外肝脏基金会估计5%美国人非酒精性脂肪肝炎

    Additionally, the liver foundation estimates that about 5 percent of Americans have NASH.

    youdao

  • 我们必须认识到所有非酒精性脂肪肝炎患者发病机制并不是单一信号途径

    I think that it probably has to do with the fact that the pathogenesis of all patients with non-alcoholic steatohepatitis, is probably not a single way or a single pathway.

    youdao

  • 新的研究包括55个非酒精性脂肪肝炎且有胰岛素抵抗2糖尿病的患者。

    The new study included 55 people with nonalcoholic steatohepatitis and either insulin resistance or type 2 diabetes.

    youdao

  • 方法选择符合条件的72酒精性脂肪肝炎患者,随机分为治疗组和对照组

    Methods 72 patients with nonalcoholic fatty liver diseases were randomly divided into two groups.

    youdao

  • 目的观察甜菜碱对实验非酒精脂肪肝炎NASH大鼠保护作用探讨可能机制

    ObjectiveTo investigate the protective effects of betaine on experimental NASH in rats and the possible mechanisms of the protective effects.

    youdao

  • 非酒精性脂肪肝炎NASH一种肝脏疾病上世纪八十年代以来逐渐认识引起重视

    Non-alcoholic steatohepatitis(NASH)is a chronic liver disease. It is known and thought highly from 1980s last century.

    youdao

  • 酒精脂肪肝炎其他脂肪肝病发病机制模型包括肝硬化进展脂质释放微梗阻的作用

    The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

    youdao

  • 非乙醇脂肪肝病NAFLD种常见肝病疾病谱包括单纯脂肪肝、非乙醇性脂肪肝炎NASH)、纤维化肝硬化

    Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.

    youdao

  • 方法对氧磷底物测定30正常人、52单纯脂肪患者、41脂肪肝炎患者、31例脂肪肝硬化患者血清pon1

    Method Serum PON1 activity was measured by using paraoxon as substrate in 30 case of norm, 52 of simple fatty liver, 41 of steatohepatitis and 31 of fatty liver cirrhosis.

    youdao

  • 结论中药抑制肝脏脂质过氧化抗其流动降低具有良好防治脂肪肝炎作用

    Conclusion: TCM may inhibit hepatic lipid peroxidation, antagonize reduction of membrane fluidity, and have better effect on preventing and treating fatty hepatitis.

    youdao

  • 结果饮食白酒灌胃8建立脂肪脂肪肝炎主要病理表现的大脂肪损伤模型

    Results: Fatty liver rat model was erected by feeding high fat diet and lavaging distillate spirit for 8 weeks, whose patho-appearance mainly was chronic fatty liver and fatty hepatitis.

    youdao

  • 阻塞睡眠呼吸暂停患者频繁夜间间歇低氧是产生脂肪肝炎危险因素

    Frequent nocturnal hypoxic episodes in patients with obstructive sleep apnea were a risk factor for developing steatohepatitis.

    youdao

  • 阻塞睡眠呼吸暂停患者频繁夜间间歇低氧是产生脂肪肝炎危险因素

    Frequent nocturnal hypoxic episodes in patients with obstructive sleep apnea were a risk factor for developing steatohepatitis.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定